Orthocell has attracted world-leading experts across medical research, clinical practice and commercialisation, each bringing deep experience in the medical device and regenerative medicine sectors.

The Chief Executive Officer and Chief Scientific Officer have played pivotal roles in securing one of Australia’s first approved cell therapy products for cartilage repair and in leading the sale of one of the country’s earliest regenerative medicine companies. 

US Leadership Team

Orthocell has appointed experienced US-based executives to drive the market launch and sales of Remplir.

John Walker

Vice President – Sales

Phillip Edmondson

Vice President – Medical Affairs

Kevin Leach

Head of Marketing

Medical Scientific Advisory Board

Orthocell has absorbed the best of Australian talent to deliver Orthocell products into global markets.

Dr David Brogan

Orthopedic Surgeon, specialising in nerve repair

Dr Christopher Dy

Orthopedic Surgeon, specialising in nerve repair

Dr Alex O’Beirne

Orthopedic Surgeon, specialising in nerve repair

Senior Management Team

Orthocell has absorbed the best of Australian talent to deliver Orthocell products into global markets. 

Gregor Maier

Vice President of Global Commercialization & Professional Engagements

Clair Lee

Director, Research & Development

Hamish Thrum

Director of Commercial, APAC

Amalia Monaco

Vice President of Manufacturing Operations

John Morri

Director of Quality

Kelly Hunter

Director, Regulatory Affairs

Senior Leadership Team

Orthocell’s Chief Executive Officer, Paul Anderson, and Chief Scientific Officer, were early pioneers in the regenerative medicine industry, having secured one of the first cell therapy products approved for cartilage repair in Australia. They, and the Executive Leadership Team execute the strategies driving Orthocell products into global markets.

Mr Paul Anderson

Chief Executive Officer and Managing Director

Professor Ming Hao Zheng

Chief Scientific Officer

Mr Jim Piper

Chief Financial Officer

Mr Alex McHenry

Chief Operating Officer

Mr Tony Macintyre

Chief Technical Operations Officer

Mr Adam Wood

Chief Commercial Officer

Board of Directors

The Orthocell Board of Directors blends strong business acumen and technical skills with international executive leadership experience. Their vision is clear, driving Orthocell products into global markets, accelerating revenue growth and supporting positive patient outcomes.

Mr John Van Der Wielen

Chairman

Mr Paul Anderson

Chief Executive Officer and Managing Director

Dr Ravi I. Thadhani

Lead Independent Director

Professor Fiona Wood AM

Non-Executive Director

Mr Michael McNulty

Non-Executive Director

Work With Us

We are proud to be working in partnership with some of the world’s most respected medical researchers, clinicians, academic institutions and sector specialists. If you would like to find out about working with us, please contact our team.

Contact us